Common supplement could help fight psoriasis, scientists discover
Monday, November 9, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
Scientists have discovered that pantethine, a readily available vitamin B5 derivative, can calm overactive immune cells and may help fight psoriasis. The supplement prevented psoriasis in mice and showed promising results in a small human trial, revealing an unexpected connection between cholesterol and autoimmune inflammation. (via Science Daily)
Read the Full StoryThis article will expire in 29 days.
In the News...
View All Recent News
- A simple supplement may help clear brain fog after cancer
- When your gut bacteria run out of fiber, they may start eating your gut lining
- Scientists discover a surprising link between acorns and lyme disease
- Common osteoporosis drugs linked to 24% lower dementia risk in major study
- Common supplement could help fight psoriasis, scientists discover
- Scientists wipe out deadly brain tumors in every mouse tested with new cancer therapy
- Einstein's equations reveal how gravity could break, reconnect, and release energy
- A little-known protein could be a major culprit in type 2 diabetes
- Low testosterone linked to 18% higher risk of dying from cancer
- Scientists discover hidden brain changes linked to common sleep disorders
- MIT scientists turn immune cells into cancer killers inside the body
- A 24-hour fast triggers a surprising repair response in the gut
- Stronger flu shot linked to nearly 55% lower Alzheimer's risk
- Scientists discover a hidden warning sign of cannabis addiction
- A compound hidden in broccoli could help fight a devastating genetic disease
- Magic mushrooms rewire the brain in a way scientists didn't expect
- Drinking 2–3 cups of coffee a day linked to dramatically lower dementia risk
- An anti-aging drug may help protect the brain before Alzheimer's symptoms begin
- For decades, we were told to avoid full-fat dairy. New research says otherwise
- Major trial challenges how doctors decide who really needs statins